TABLE 1.
Standard | Mean (1 – 5 scale) | |
---|---|---|
Psychosocial leaders (n=132) |
Oncologists (n=99) |
|
PSS1: Assessment of psychosocial healthcare needs | 4.66 | 4.58 |
PSS2: Monitoring of neurocognitive problems | 4.15 | 4.15 |
PSS3: Screening in long-term survivorship | 3.98 | 4.05 |
PSS4: Psychosocial support and intervention | 4.59 | 4.46 |
PSS5: Assessment of financial need (at diagnosis) | 4.50 | 4.43 |
PSS5: Assessment of financial need (ongoing)1 | 4.18 | 3.91 |
PSS5: Assessment factors ‥ access to care (initial) | 4.74 | 4.60 |
PSS5: Assessment factors ‥ access to care (ongoing)2 | 4.46 | 4.11 |
PSS6: Parental mental health | 4.33 | 4.11 |
PSS7: Psychoeducation, information, anticipatory guidance3 | 4.58 | 4.11 |
PSS8: Preparatory information about invasive procedures | 4.19 | 4.09 |
PSS8: Psychosocial interventions for invasive procedures | 3.88 | 3.88 |
PSS9: Opportunities for social interaction4 | 3.82 | 4.12 |
PSS10: Psychosocial support and interventions for siblings | 3.61 | 3.69 |
PSS11: Support for school re-entry | 4.25 | 4.34 |
PSS12: Adherence to treatment is assessed and monitored | 4.39 | 4.49 |
PSS13: Palliative care concepts throughout disease process | 3.17 | 3.21 |
PSS13: Developmentally appropriate end of life care | 4.61 | 4.51 |
PSS14: Psychosocial care after a child’s death | 3.79 | 4.00 |
Note: Reported p values for the Mann-Whitney U test comparison of means
p = .041
p = .002
p = .000
p = .006